Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

SB-258585

From Wikipedia, the free encyclopedia
(Redirected fromSB-258,585)
Chemical compound
Pharmaceutical compound
SB-258585
Identifiers
  • 4-Iodo-N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]benzenesulfonamide
CAS Number
PubChemCID
IUPHAR/BPS
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC18H22IN3O3S
Molar mass487.36 g·mol−1
3D model (JSmol)
  • C3CN(C)CCN3c1cc(ccc1OC)NS(=O)(=O)c2ccc(I)cc2
  • InChI=1S/C18H22IN3O3S/c1-21-9-11-22(12-10-21)17-13-15(5-8-18(17)25-2)20-26(23,24)16-6-3-14(19)4-7-16/h3-8,13,20H,9-12H2,1-2H3 ☒N
  • Key:BDHMSYNBSBZCAF-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

SB-258585 is a drug which is used in scientific research. It acts as a potent, selective and orally active5-HT6receptorantagonist, with aKi of 8.9nM.[1] It is used in its125Iradiolabelled form to map the distribution of 5-HT6 receptors in the brain.[2][3]

SB-258585 and other 5-HT6 antagonists shownootropic effects in animal studies,[4][5] as well asantidepressant andanxiolytic effects,[6] and have been proposed as potential novel treatments for cognitive disorders such asschizophrenia andAlzheimer's disease.

References

[edit]
  1. ^Hirst WD, Minton JA, Bromidge SM, Moss SF, Latter AJ, Riley G, et al. (August 2000)."Characterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissue".British Journal of Pharmacology.130 (7):1597–605.doi:10.1038/sj.bjp.0703458.PMC 1572217.PMID 10928963.
  2. ^Roberts JC, Reavill C, East SZ, Harrison PJ, Patel S, Routledge C, Leslie RA (April 2002). "The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585".Brain Research.934 (1):49–57.doi:10.1016/S0006-8993(02)02360-0.PMID 11937069.S2CID 140209933.
  3. ^East SZ, Burnet PW, Leslie RA, Roberts JC, Harrison PJ (September 2002). "5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585".Synapse.45 (3):191–9.doi:10.1002/syn.10097.PMID 12112397.S2CID 25909618.
  4. ^Stean TO, Hirst WD, Thomas DR, Price GW, Rogers D, Riley G, et al. (April 2002). "Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonist".Pharmacology, Biochemistry, and Behavior.71 (4):645–54.doi:10.1016/S0091-3057(01)00742-0.PMID 11888556.S2CID 34925312.
  5. ^Loiseau F, Dekeyne A, Millan MJ (January 2008). "Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex".Psychopharmacology.196 (1):93–104.doi:10.1007/s00213-007-0934-5.PMID 17922111.S2CID 35795618.
  6. ^Wesołowska A, Nikiforuk A, Stachowicz K (September 2007). "Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats".Behavioural Pharmacology.18 (5–6):439–46.doi:10.1097/FBP.0b013e3282d28f9c.PMID 17762512.S2CID 20105974.
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Simple piperazines
(no additional rings)
Phenylpiperazines
Benzylpiperazines
Diphenylalkylpiperazines
(benzhydrylalkylpiperazines)
Pyrimidinylpiperazines
Pyridinylpiperazines
Benzo(iso)thiazolylpiperazines
Tricyclics
(piperazine attached via side chain)
Others/Uncategorized
Stub icon

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=SB-258585&oldid=1247273151"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp